# Coca-Cola Consolidated, Inc.: overview

COKE · Nasdaq · CIK 317540 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/coke.md) · [Financials](/companies/coke/financials.md) · [Filings](/companies/coke/filings.md) · [Insiders](/companies/coke/insiders.md)

Latest reported revenue: [$2.05bn](/filings/0001628280-26-053370.md) for Q2 FY2026, three months to 2026-07-03, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053370).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,766](/filings/0001628280-25-047124.md) | [1,746 d](/filings/0001628280-26-009057.md) | [1,580](/filings/0001628280-26-031302.md) | [1,856](/filings/0001628280-26-053370.md) | [1,888](/filings/0001628280-25-047124.md) | [1,904 d](/filings/0001628280-26-009057.md) | [1,847](/filings/0001628280-26-031302.md) | [2,052](/filings/0001628280-26-053370.md) |
| Gross margin | % | [39.5%](/filings/0001628280-25-047124.md) | [40.0% d](/filings/0001628280-26-009057.md) | [39.7%](/filings/0001628280-26-031302.md) | [40.0%](/filings/0001628280-26-053370.md) | [39.6%](/filings/0001628280-25-047124.md) | [39.6% d](/filings/0001628280-26-009057.md) | [39.4%](/filings/0001628280-26-031302.md) | [37.9%](/filings/0001628280-26-053370.md) |
| Operating margin | % | [12.9%](/filings/0001628280-25-047124.md) | [12.5% d](/filings/0001628280-26-009057.md) | [12.0%](/filings/0001628280-26-031302.md) | [14.7%](/filings/0001628280-26-053370.md) | [13.1%](/filings/0001628280-25-047124.md) | [12.7% d](/filings/0001628280-26-009057.md) | [12.9%](/filings/0001628280-26-031302.md) | [13.2%](/filings/0001628280-26-053370.md) |
| Net margin | % | [6.5%](/filings/0001628280-25-047124.md) | [10.2% d](/filings/0001628280-26-009057.md) | [6.6%](/filings/0001628280-26-031302.md) | [10.1%](/filings/0001628280-26-053370.md) | [7.5%](/filings/0001628280-25-047124.md) | [7.2% d](/filings/0001628280-26-009057.md) | [6.0%](/filings/0001628280-26-031302.md) | [7.7%](/filings/0001628280-26-053370.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [143 d](/filings/0001628280-25-047124.md) | [84.8 d](/filings/0001628280-26-009057.md) | [100](/filings/0001628280-26-031302.md) | [149 d](/filings/0001628280-26-053370.md) | [264 d](/filings/0001628280-25-047124.md) | [107 d](/filings/0001628280-26-009057.md) | [142](/filings/0001628280-26-031302.md) | [131 d](/filings/0001628280-26-053370.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,563](/filings/0000317540-24-000009.md) | [6,201](/filings/0000317540-25-000025.md) | [6,654](/filings/0001628280-26-009057.md) | [6,900](/filings/0001628280-26-009057.md) | [7,228](/filings/0001628280-26-009057.md) |
| Gross margin | % | [35.1%](/filings/0000317540-24-000009.md) | [36.7%](/filings/0000317540-25-000025.md) | [39.1%](/filings/0001628280-26-009057.md) | [39.9%](/filings/0001628280-26-009057.md) | [39.7%](/filings/0001628280-26-009057.md) |
| Operating margin | % | [7.9%](/filings/0000317540-24-000009.md) | [10.3%](/filings/0000317540-25-000025.md) | [12.5%](/filings/0001628280-26-009057.md) | [13.3%](/filings/0001628280-26-009057.md) | [13.2%](/filings/0001628280-26-009057.md) |
| Net margin | % | [3.4%](/filings/0000317540-24-000009.md) | [6.9%](/filings/0000317540-25-000025.md) | [6.1%](/filings/0001628280-26-009057.md) | [9.2%](/filings/0001628280-26-009057.md) | [7.9%](/filings/0001628280-26-009057.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [366](/filings/0000317540-24-000009.md) | [256](/filings/0000317540-25-000025.md) | [528](/filings/0001628280-26-009057.md) | [505](/filings/0001628280-26-009057.md) | [620](/filings/0001628280-26-009057.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/coke/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.02bn | 5,328,834 |  | Added +83,747 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $568.7m | 2,978,517 |  | Added +19,433 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $487.8m | 2,555,206 |  | Added +14,003 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $436.3m | 2,285,642 |  | Added +275,530 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $373.2m | 1,954,502 |  | Reduced −62,866 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $341.6m | 1,789,028 |  | Added +44,864 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $321.8m | 1,685,150 |  | Added +77,491 |
| [DIVERSIFIED TRUST CO](/funds/1479844.md) | 2026-06-30 | $280.1m | 1,466,859 |  | Added +3,177 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $253.9m | 1,329,808 |  | Added +41,557 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $251.9m | 1,319,285 |  | New +1,319,285 |

## Recent filings

[All 485 filings](/companies/coke/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:16 ET | [10-Q](/filings/0001628280-26-053370.md) | Quarterly report, period 2026-07-03 | 0001628280-26-053370 |
| 2026-08-05 | 16:13 ET | [8-K](/filings/0001628280-26-053365.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053365 |
| 2026-05-13 | 16:06 ET | [8-K](/filings/0001628280-26-034592.md) | 5.07 Shareholder vote results | 0001628280-26-034592 |
| 2026-05-06 | 16:20 ET | [10-Q](/filings/0001628280-26-031302.md) | Quarterly report, period 2026-04-03 | 0001628280-26-031302 |
| 2026-05-06 | 16:17 ET | [8-K](/filings/0001628280-26-031296.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031296 |
| 2026-03-23 | 16:15 ET | [DEF 14A](/filings/0001628280-26-020505.md) | Proxy statement, period 2026-05-12 | 0001628280-26-020505 |
| 2026-02-26 | 17:28 ET | [SCHEDULE 13D/A](/filings/0001193125-26-077460.md) | Ownership report, active investor, amended | 0001193125-26-077460 |
| 2026-02-18 | 16:17 ET | [10-K](/filings/0001628280-26-009057.md) | Annual report, period 2025-12-31 | 0001628280-26-009057 |
| 2026-02-18 | 16:14 ET | [8-K](/filings/0001628280-26-009048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-009048 |
| 2025-12-08 | 16:17 ET | [8-K](/filings/0001628280-25-055830.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-25-055830 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-009057.md), filed Feb 18, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 317540
- Tickers: COKE
- Exchange: Nasdaq
- SIC code: 2086 Bottled & Canned Soft Drinks & Carbonated Waters
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.